Post by
RazeKreations on Jan 05, 2023 1:49pm
Microbix is in a better position than it has ever been
Overall the Q4 results although being a little dissapointing those results were not a surprise.
There had been so little information for the last six months that, gave it away.
There is so much instability around the world with the high inflation and interest rates as well as the geopolitical scene between Russia and Ukraine as well as the growing threat between China,USA and Taiwan wich brings a lot of concern for investors.
Microbix is in a very good position to weather these storms and survive. Although 2022 was dissapointing they still made record income and grew cash balances as well as paying down debt, as well as improving control systems and equipment for future growth.
Much of the poorer than expected results came from the fact that customers have not gotten final regulatory approvals for the testing equipment that Microbix is going to supply then Qap's for. Which was a surprise expressed by Cameron.
When all the regulatory approvals are finished the qap's sales will pickup substantially.
Cameron said that the first half of the year would be slow then it would pickup in the last half. If he was talking about the fiscal year, then we are into the second quarter now and end of March would end second quarter and the first half of the year.
Kinlytic.................It drives me crazy, just because it has been promoted for over 20 years. But it is beginning to look like it may finally have a chance to go forward with the shortage of Urokinaise around the worls and a growing demand.
Microbix is in a better position than it has ever been and is ready to take advantage of opportunities when they come.